Fortress Biotech (FBIO)

Aevitas Therapeutics, Inc. • Avenue Therapeutics, Inc. • Cellvation, Inc. • Checkpoint Therapeutics, Inc. • Cyprium Therapeutics, Inc. • Helocyte, Inc. • Journey Medical Corporation • Mustang Bio, Inc. • Oncogenuity, Inc. • Urica Therapeutics, Inc. ...

IRS number

205157386

FBIO stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

14 Nov 24

Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

Prospectus supplement

25 Oct 24

EFFECT

Notice of effectiveness

8 Oct 24

424B3

Prospectus supplement

Transcripts

Earnings call transcript

2022 Q3

11 Nov 22

FBIO

Earnings call transcript

2022 Q2

10 Aug 22

Latest ownership filings

View all

Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc.

3 Jan 25

SC 13D/A

AVENUE THERAPEUTICS, INC.

3 Jan 25

J JAY LOBELL

3 Jan 25

AVENUE THERAPEUTICS, INC.

Financial summary

Financial statements Chart FBIO financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	60.92 mm	60.92 mm	60.92 mm	60.92 mm	60.92 mm	60.92 mm
Cash burn (monthly)	5.78 mm	1.15 mm	8.88 mm	9.97 mm	6.69 mm	8.52 mm
Cash used (since last report)	29.39 mm	5.86 mm	45.10 mm	50.64 mm	33.98 mm	43.29 mm
Cash remaining	31.53 mm	55.06 mm	15.81 mm	10.27 mm	26.94 mm	17.63 mm
Runway (months of cash)	5.5	47.8	1.8	1.0	4.0	2.1

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q4 2024

FBIO institutional ownership history Ownership history

39.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	54	51	+5.9%
Opened positions	11	6	+83.3%
Closed positions	8	6	+33.3%
Increased positions	22	22	–
Reduced positions	11	11	–

13F shares	Current	Prev Q	Change
Total value	6.74 bn	4.39 bn	+53.4%
Total shares	10.84 mm	13.23 mm	-18.1%
Total puts	79.40 k	20.50 k	+287.3%
Total calls	29.70 k	25.60 k	+16.0%
Total put/call ratio	2.7	0.8	+233.8%

Largest owners	Shares	Value	Change
Katz Daryl	6.05 mm	$4.60 mm	0.0%
Cambridge Investment Research Advisors	924.31 k	$1.87 mm	+66.7%
Vanguard	625.05 k	$1.27 bn	0.0%
PVG Asset Management	386.30 k	$782.25 mm	+3.3%
Envestnet Asset Management	239.59 k	$485.18 mm	+30.3%
Shikiar Asset Management	235.97 k	$477.00 k	0.0%
Kestra Advisory Services	226.23 k	$458.12 mm	NEW
Geode Capital Management	204.54 k	$414.23 mm	+21.3%
Acadian Asset Management	185.48 k	$375.00 k	-61.6%
Renaissance Technologies	175.80 k	$356.00 mm	+125.1%

Largest transactions	Shares	Bought/sold	Change
Highbridge Capital Management	0.00	-2.73 mm	EXIT
Rosalind Advisors	0.00	-502.83 k	EXIT
Cambridge Investment Research Advisors	924.31 k	+369.91 k	+66.7%
Acadian Asset Management	185.48 k	-297.12 k	-61.6%
Kestra Advisory Services	226.23 k	+226.23 k	NEW
Citadel Advisors	175.76 k	+140.20 k	+394.2%
Renaissance Technologies	175.80 k	+97.71 k	+125.1%
Envestnet Asset Management	239.59 k	+55.65 k	+30.3%
Two Sigma Investments	54.05 k	+54.05 k	NEW
HB Wealth Management	106.85 k	+51.52 k	+93.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

FBIO insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	#Shares	#Remaining
26 Feb 25	Fortress Biotech	COMMON STOCK, PAR VALUE $0.0001	Grant	Acquire A	No	No	18,500	6,222,249
1 Jan 25	Dov Klein	common stock, par value $0.001	Grant	Acquire A	No	No	49,383	102,783
1 Jan 25	Jimmie Harvey	common stock, par value $0.001	Grant	Acquire A	No	No	49,383	119,382
1 Jan 25	Lorenz Kevin	common stock, par value $0.001	Grant	Acquire A	No	No	49,383	73,687
1 Jan 25	Lucy Lu	common stock, par value $0.001	Grant	Acquire A	No	No	49,383	61,273